{"hands_on_practices": [{"introduction": "This exercise models the critical balance of nitric oxide ($NO$) bioavailability, a cornerstone of endothelial health. By applying principles of steady-state chemical kinetics, you will quantify how increased oxidative stress, a hallmark of early atherosclerosis, directly depletes this protective signaling molecule. This practice offers a quantitative understanding of endothelial dysfunction at its molecular roots [@problem_id:4913177].", "problem": "Endothelial nitric oxide (NO) bioavailability in the arterial wall is a determinant of vascular tone and is disrupted in atherosclerosis due to increased reactive oxygen species. Consider a single-compartment endothelial model in which endothelial nitric oxide synthase (eNOS) produces nitric oxide at a constant rate $k_{\\mathrm{prod}}$ (zero-order production), nitric oxide is removed by first-order decay with rate constant $k_{\\mathrm{decay}}$, and nitric oxide reacts with superoxide ($O_{2}^{-}$) to form peroxynitrite (ONOO$^{-}$) with a bimolecular rate constant $k_{\\mathrm{ONOO}}$. Under the assumption of steady state (net rate of change of nitric oxide concentration equals zero) and mass-action kinetics, the nitric oxide balance is\n$$\n0 \\;=\\; k_{\\mathrm{prod}} \\;-\\; k_{\\mathrm{decay}}[NO] \\;-\\; k_{\\mathrm{ONOO}}[NO][O_{2}^{-}] \\, .\n$$\nLet the baseline superoxide concentration be $S = [O_{2}^{-}]$. Starting from the steady-state balance and fundamental mass-action principles, derive the closed-form expression for the steady-state nitric oxide concentration $[NO]$ as a function of $k_{\\mathrm{prod}}$, $k_{\\mathrm{decay}}$, $k_{\\mathrm{ONOO}}$, and $S$. Then, quantify the impact of a twofold increase in superoxide (i.e., $[O_{2}^{-}]$ changes from $S$ to $2S$) on nitric oxide by computing the fold-change in nitric oxide concentration, defined as $\\frac{[NO]_{\\text{after}}}{[NO]_{\\text{before}}}$. Express your final answer as a single simplified analytic expression in $k_{\\mathrm{decay}}$, $k_{\\mathrm{ONOO}}$, and $S$. No numerical evaluation is required; no rounding is needed. The fold-change is dimensionless; do not include units in your final expression.", "solution": "The problem statement has been critically validated and is deemed valid. It is scientifically grounded in established principles of chemical kinetics and vascular biology, is well-posed, and all terms are formally and objectively defined. It presents a solvable problem without any internal contradictions, missing information, or reliance on pseudoscience. We may therefore proceed with a formal solution.\n\nThe problem requires the derivation of the fold-change in steady-state nitric oxide concentration, $[NO]$, following a twofold increase in superoxide concentration, $[O_{2}^{-}]$. The analysis begins with the provided steady-state balance equation for nitric oxide:\n$$\n0 \\;=\\; k_{\\mathrm{prod}} \\;-\\; k_{\\mathrm{decay}}[NO] \\;-\\; k_{\\mathrm{ONOO}}[NO][O_{2}^{-}]\n$$\nwhere $k_{\\mathrm{prod}}$ is the zero-order production rate, $k_{\\mathrm{decay}}$ is the first-order decay rate constant, and $k_{\\mathrm{ONOO}}$ is the bimolecular rate constant for the reaction between $NO$ and $O_{2}^{-}$.\n\nFirst, we will determine the initial or baseline steady-state nitric oxide concentration, which we denote as $[NO]_{\\text{before}}$. At baseline, the superoxide concentration is given as $[O_{2}^{-}] = S$. Substituting this into the balance equation gives:\n$$\n0 \\;=\\; k_{\\mathrm{prod}} \\;-\\; k_{\\mathrm{decay}}[NO]_{\\text{before}} \\;-\\; k_{\\mathrm{ONOO}}[NO]_{\\text{before}}S\n$$\nTo solve for $[NO]_{\\text{before}}$, we rearrange the equation to isolate the terms containing $[NO]_{\\text{before}}$:\n$$\nk_{\\mathrm{decay}}[NO]_{\\text{before}} + k_{\\mathrm{ONOO}}[NO]_{\\text{before}}S \\;=\\; k_{\\mathrm{prod}}\n$$\nFactoring out $[NO]_{\\text{before}}$ from the left-hand side yields:\n$$\n[NO]_{\\text{before}} \\left( k_{\\mathrm{decay}} + k_{\\mathrm{ONOO}}S \\right) \\;=\\; k_{\\mathrm{prod}}\n$$\nSolving for $[NO]_{\\text{before}}$ by dividing by the term in parentheses, we obtain the expression for the baseline nitric oxide concentration:\n$$\n[NO]_{\\text{before}} \\;=\\; \\frac{k_{\\mathrm{prod}}}{k_{\\mathrm{decay}} + k_{\\mathrm{ONOO}}S}\n$$\n\nNext, we consider the condition where the superoxide concentration is increased twofold. The new superoxide concentration is $[O_{2}^{-}] = 2S$. We denote the corresponding new steady-state nitric oxide concentration as $[NO]_{\\text{after}}$. The balance equation under this new condition is:\n$$\n0 \\;=\\; k_{\\mathrm{prod}} \\;-\\; k_{\\mathrm{decay}}[NO]_{\\text{after}} \\;-\\; k_{\\mathrm{ONOO}}[NO]_{\\text{after}}(2S)\n$$\nFollowing the same algebraic procedure as before, we first rearrange the equation:\n$$\nk_{\\mathrm{decay}}[NO]_{\\text{after}} + 2k_{\\mathrm{ONOO}}[NO]_{\\text{after}}S \\;=\\; k_{\\mathrm{prod}}\n$$\nFactoring out $[NO]_{\\text{after}}$ gives:\n$$\n[NO]_{\\text{after}} \\left( k_{\\mathrm{decay}} + 2k_{\\mathrm{ONOO}}S \\right) \\;=\\; k_{\\mathrm{prod}}\n$$\nSolving for $[NO]_{\\text{after}}$, we find the expression for the nitric oxide concentration after the increase in superoxide:\n$$\n[NO]_{\\text{after}} \\;=\\; \\frac{k_{\\mathrm{prod}}}{k_{\\mathrm{decay}} + 2k_{\\mathrm{ONOO}}S}\n$$\n\nFinally, we compute the fold-change in nitric oxide concentration, which is defined as the ratio of the final concentration to the initial concentration, $\\frac{[NO]_{\\text{after}}}{[NO]_{\\text{before}}}$.\nSubstituting the expressions we derived for $[NO]_{\\text{after}}$ and $[NO]_{\\text{before}}$:\n$$\n\\text{Fold-change} \\;=\\; \\frac{[NO]_{\\text{after}}}{[NO]_{\\text{before}}} \\;=\\; \\frac{\\frac{k_{\\mathrm{prod}}}{k_{\\mathrm{decay}} + 2k_{\\mathrm{ONOO}}S}}{\\frac{k_{\\mathrm{prod}}}{k_{\\mathrm{decay}} + k_{\\mathrm{ONOO}}S}}\n$$\nTo simplify this complex fraction, we multiply the numerator by the reciprocal of the denominator:\n$$\n\\text{Fold-change} \\;=\\; \\frac{k_{\\mathrm{prod}}}{k_{\\mathrm{decay}} + 2k_{\\mathrm{ONOO}}S} \\times \\frac{k_{\\mathrm{decay}} + k_{\\mathrm{ONOO}}S}{k_{\\mathrm{prod}}}\n$$\nThe production rate constant, $k_{\\mathrm{prod}}$, cancels out, yielding the final simplified expression for the fold-change:\n$$\n\\text{Fold-change} \\;=\\; \\frac{k_{\\mathrm{decay}} + k_{\\mathrm{ONOO}}S}{k_{\\mathrm{decay}} + 2k_{\\mathrm{ONOO}}S}\n$$\nThis expression quantifies the fractional reduction in steady-state nitric oxide bioavailability resulting from a doubling of the superoxide concentration, expressed solely in terms of the decay rate constant $k_{\\mathrm{decay}}$, the bimolecular rate constant $k_{\\mathrm{ONOO}}$, and the baseline superoxide concentration $S$.", "answer": "$$\\boxed{\\frac{k_{\\mathrm{decay}} + k_{\\mathrm{ONOO}}S}{k_{\\mathrm{decay}} + 2k_{\\mathrm{ONOO}}S}}$$", "id": "4913177"}, {"introduction": "We now move from molecular signals to the cellular hallmark of atherosclerosis: the formation of lipid-laden foam cells. This practice challenges you to build a mass-balance model for cholesterol trafficking within a plaque macrophage, integrating rates of uptake, intracellular processing, and efflux governed by Michaelis–Menten kinetics. By solving this model [@problem_id:4913173], you will determine the net cholesterol accumulation rate, providing a quantitative basis for understanding how impaired efflux pathways lead to the foam cell phenotype.", "problem": "A plaque macrophage internalizes cholesteryl esters from modified Low-Density Lipoprotein (LDL) via scavenger receptors, hydrolyzes them to free cholesterol in lysosomes by Lysosomal Acid Lipase (LAL), re-esterifies free cholesterol in the endoplasmic reticulum by Acyl-CoA:cholesterol acyltransferase (ACAT), and exports free cholesterol to extracellular acceptors through ATP Binding Cassette transporter A1 (ABCA1) to Apolipoprotein A-I (apoA-I) and ATP Binding Cassette transporter G1 (ABCG1) to High-Density Lipoprotein (HDL). Consider a single-cell mass balance with two intracellular cholesterol pools: cholesteryl ester ($M_{\\mathrm{CE}}(t)$) and free cholesterol ($M_{\\mathrm{FC}}(t)$), and define total cellular cholesterol mass $M_{\\mathrm{tot}}(t) = M_{\\mathrm{CE}}(t) + M_{\\mathrm{FC}}(t)$ expressed per milligram of cell protein.\n\nAssume:\n- Modified LDL uptake delivers cholesteryl ester at a constant rate $V_{\\mathrm{uptake}} = 6.0 \\ \\mathrm{nmol \\ mg^{-1} \\ h^{-1}}$.\n- LAL hydrolysis of cholesteryl ester to free cholesterol follows Michaelis–Menten kinetics with $V_{\\max,\\mathrm{LAL}} = 9.0 \\ \\mathrm{nmol \\ mg^{-1} \\ h^{-1}}$, $K_{m,\\mathrm{LAL}} = 40 \\ \\mathrm{nmol \\ mg^{-1}}$, and the initial cholesteryl ester pool $M_{\\mathrm{CE}}(0) = 160 \\ \\mathrm{nmol \\ mg^{-1}}$. Over the time window considered, you may treat $M_{\\mathrm{CE}}(t)$ as large enough that LAL operates near its steady, substrate-saturated regime implied by the given parameters.\n- ACAT re-esterification of free cholesterol follows Michaelis–Menten kinetics with $V_{\\max,\\mathrm{ACAT}} = 8.0 \\ \\mathrm{nmol \\ mg^{-1} \\ h^{-1}}$, $K_{m,\\mathrm{ACAT}} = 30 \\ \\mathrm{nmol \\ mg^{-1}}$.\n- Free cholesterol efflux comprises two saturable components evaluated at a homeostatic free cholesterol set point $M_{\\mathrm{FC}}^{*} = 50 \\ \\mathrm{nmol \\ mg^{-1}}$ maintained by rapid ACAT buffering and sterol-driven feedback. The ABCA1–apoA-I pathway has $V_{\\max,\\mathrm{ABCA1}} = 5.0 \\ \\mathrm{nmol \\ mg^{-1} \\ h^{-1}}$, $K_{m,\\mathrm{ABCA1}} = 25 \\ \\mathrm{nmol \\ mg^{-1}}$, and the ABCG1–HDL pathway has $V_{\\max,\\mathrm{ABCG1}} = 3.0 \\ \\mathrm{nmol \\ mg^{-1} \\ h^{-1}}$, $K_{m,\\mathrm{ABCG1}} = 40 \\ \\mathrm{nmol \\ mg^{-1}}$.\n\nStarting from the principles of mass conservation and enzyme transport kinetics, and assuming the free cholesterol pool is maintained near $M_{\\mathrm{FC}}^{*}$ over the time horizon, derive the expression for the net rate of change of total cellular cholesterol $dM_{\\mathrm{tot}}/dt$ as determined by external influx and efflux. Recognize that actual efflux cannot exceed the instantaneous free cholesterol supply produced by hydrolysis minus re-esterification when $M_{\\mathrm{FC}}(t)$ is clamped near $M_{\\mathrm{FC}}^{*}$.\n\nUsing the parameter values above, compute the net change in total cholesterol mass $\\Delta M_{\\mathrm{tot}}$ over a duration $\\tau = 8.0 \\ \\mathrm{h}$. Express your final answer in $\\mathrm{nmol \\ mg^{-1}}$ and round to four significant figures.", "solution": "The problem asks for the net change in total cellular cholesterol mass, $\\Delta M_{\\mathrm{tot}}$, in a macrophage over a specified time period. The solution requires applying the principle of mass conservation to the intracellular cholesterol pools and evaluating the rates of metabolic/transport processes using the provided kinetic parameters.\n\nFirst, we establish the mass balance equations for the two specified cholesterol pools: cholesteryl esters, $M_{\\mathrm{CE}}(t)$, and free cholesterol, $M_{\\mathrm{FC}}(t)$. The rates of change are given by:\n$$ \\frac{dM_{\\mathrm{CE}}}{dt} = V_{\\mathrm{uptake}} - V_{\\mathrm{LAL}} + V_{\\mathrm{ACAT}} $$\n$$ \\frac{dM_{\\mathrm{FC}}}{dt} = V_{\\mathrm{LAL}} - V_{\\mathrm{ACAT}} - V_{\\mathrm{efflux}} $$\n\nHere, $V_{\\mathrm{uptake}}$ is the rate of cholesteryl ester influx from modified LDL. $V_{\\mathrm{LAL}}$ is the rate of cholesteryl ester hydrolysis to free cholesterol by Lysosomal Acid Lipase. $V_{\\mathrm{ACAT}}$ is the rate of free cholesterol re-esterification to cholesteryl ester by Acyl-CoA:cholesterol acyltransferase. $V_{\\mathrm{efflux}}$ is the rate of free cholesterol export out of the cell via the ABCA1 and ABCG1 transporters.\n\nThe total cellular cholesterol mass is defined as $M_{\\mathrm{tot}}(t) = M_{\\mathrm{CE}}(t) + M_{\\mathrm{FC}}(t)$. We are interested in its rate of change, $\\frac{dM_{\\mathrm{tot}}}{dt}$. By summing the two mass balance equations, we get:\n$$ \\frac{dM_{\\mathrm{tot}}}{dt} = \\frac{dM_{\\mathrm{CE}}}{dt} + \\frac{dM_{\\mathrm{FC}}}{dt} = (V_{\\mathrm{uptake}} - V_{\\mathrm{LAL}} + V_{\\mathrm{ACAT}}) + (V_{\\mathrm{LAL}} - V_{\\mathrm{ACAT}} - V_{\\mathrm{efflux}}) $$\nThe internal conversion terms, $V_{\\mathrm{LAL}}$ and $V_{\\mathrm{ACAT}}$, cancel out, simplifying the expression to:\n$$ \\frac{dM_{\\mathrm{tot}}}{dt} = V_{\\mathrm{uptake}} - V_{\\mathrm{efflux}} $$\nThis equation shows that the change in total cellular cholesterol is solely determined by the balance between the influx of cholesterol into the cell and the efflux of cholesterol out of the cell.\n\nThe problem's assumptions allow us to calculate these rates as constants.\nThe influx rate is given as a constant:\n$$ V_{\\mathrm{uptake}} = 6.0 \\ \\mathrm{nmol \\ mg^{-1} \\ h^{-1}} $$\n\nThe efflux rate, $V_{\\mathrm{efflux}}$, must be determined. It is the sum of efflux through the ABCA1 and ABCG1 pathways, $V_{\\mathrm{efflux}} = V_{\\mathrm{ABCA1}} + V_{\\mathrm{ABCG1}}$. However, the problem provides a crucial constraint: \"actual efflux cannot exceed the instantaneous free cholesterol supply produced by hydrolysis minus re-esterification\". This means we must first calculate the potential efflux rate based on transporter kinetics and then compare it to the rate of free cholesterol supply.\n\nLet's calculate the rate of net free cholesterol supply, $V_{\\mathrm{supply, FC}} = V_{\\mathrm{LAL}} - V_{\\mathrm{ACAT}}$.\nThe LAL hydrolysis rate follows Michaelis-Menten kinetics. The problem states that LAL operates near saturation, and we should use the conditions \"implied by the given parameters\". This directs us to calculate the rate at the given initial substrate concentration $M_{\\mathrm{CE}}(0) = 160 \\ \\mathrm{nmol \\ mg^{-1}}$.\n$$ V_{\\mathrm{LAL}} = V_{\\max,\\mathrm{LAL}} \\frac{M_{\\mathrm{CE}}(0)}{K_{m,\\mathrm{LAL}} + M_{\\mathrm{CE}}(0)} = 9.0 \\ \\frac{160}{40 + 160} = 9.0 \\ \\frac{160}{200} = 9.0 \\times 0.8 = 7.2 \\ \\mathrm{nmol \\ mg^{-1} \\ h^{-1}} $$\nThe ACAT re-esterification rate also follows Michaelis-Menten kinetics. It depends on the free cholesterol concentration, which is assumed to be maintained at the homeostatic set point $M_{\\mathrm{FC}}^{*} = 50 \\ \\mathrm{nmol \\ mg^{-1}}$.\n$$ V_{\\mathrm{ACAT}} = V_{\\max,\\mathrm{ACAT}} \\frac{M_{\\mathrm{FC}}^{*}}{K_{m,\\mathrm{ACAT}} + M_{\\mathrm{FC}}^{*}} = 8.0 \\ \\frac{50}{30 + 50} = 8.0 \\ \\frac{50}{80} = 8.0 \\times 0.625 = 5.0 \\ \\mathrm{nmol \\ mg^{-1} \\ h^{-1}} $$\nThe net supply of free cholesterol available for efflux is therefore:\n$$ V_{\\mathrm{supply, FC}} = V_{\\mathrm{LAL}} - V_{\\mathrm{ACAT}} = 7.2 - 5.0 = 2.2 \\ \\mathrm{nmol \\ mg^{-1} \\ h^{-1}} $$\n\nNext, we calculate the potential efflux rate, $V_{\\mathrm{efflux, potential}}$, which is the maximum rate at which the transporters can export cholesterol given the substrate concentration $M_{\\mathrm{FC}}^{*}$.\nThe rate for the ABCA1 pathway is:\n$$ V_{\\mathrm{ABCA1}} = V_{\\max,\\mathrm{ABCA1}} \\frac{M_{\\mathrm{FC}}^{*}}{K_{m,\\mathrm{ABCA1}} + M_{\\mathrm{FC}}^{*}} = 5.0 \\ \\frac{50}{25 + 50} = 5.0 \\ \\frac{50}{75} = 5.0 \\times \\frac{2}{3} = \\frac{10}{3} \\ \\mathrm{nmol \\ mg^{-1} \\ h^{-1}} $$\nThe rate for the ABCG1 pathway is:\n$$ V_{\\mathrm{ABCG1}} = V_{\\max,\\mathrm{ABCG1}} \\frac{M_{\\mathrm{FC}}^{*}}{K_{m,\\mathrm{ABCG1}} + M_{\\mathrm{FC}}^{*}} = 3.0 \\ \\frac{50}{40 + 50} = 3.0 \\ \\frac{50}{90} = 3.0 \\times \\frac{5}{9} = \\frac{5}{3} \\ \\mathrm{nmol \\ mg^{-1} \\ h^{-1}} $$\nThe total potential efflux rate is the sum of the two:\n$$ V_{\\mathrm{efflux, potential}} = V_{\\mathrm{ABCA1}} + V_{\\mathrm{ABCG1}} = \\frac{10}{3} + \\frac{5}{3} = \\frac{15}{3} = 5.0 \\ \\mathrm{nmol \\ mg^{-1} \\ h^{-1}} $$\n\nNow we apply the supply constraint. The actual efflux rate, $V_{\\mathrm{efflux, actual}}$, is the minimum of the potential rate and the supply rate:\n$$ V_{\\mathrm{efflux, actual}} = \\min(V_{\\mathrm{efflux, potential}}, V_{\\mathrm{supply, FC}}) = \\min(5.0, 2.2) = 2.2 \\ \\mathrm{nmol \\ mg^{-1} \\ h^{-1}} $$\nThis indicates that cholesterol efflux is limited by its net production rate within the cell, not by the capacity of the efflux transporters.\n\nWith the actual efflux rate determined, we can calculate the net rate of change of total cellular cholesterol:\n$$ \\frac{dM_{\\mathrm{tot}}}{dt} = V_{\\mathrm{uptake}} - V_{\\mathrm{efflux, actual}} = 6.0 - 2.2 = 3.8 \\ \\mathrm{nmol \\ mg^{-1} \\ h^{-1}} $$\nThe positive rate indicates that the macrophage is accumulating cholesterol, consistent with foam cell formation.\n\nFinally, we calculate the total net change, $\\Delta M_{\\mathrm{tot}}$, over the specified duration $\\tau = 8.0 \\ \\mathrm{h}$. Since the rate is constant, the change is the rate multiplied by the time interval:\n$$ \\Delta M_{\\mathrm{tot}} = \\left( \\frac{dM_{\\mathrm{tot}}}{dt} \\right) \\times \\tau = (3.8 \\ \\mathrm{nmol \\ mg^{-1} \\ h^{-1}}) \\times (8.0 \\ \\mathrm{h}) = 30.4 \\ \\mathrm{nmol \\ mg^{-1}} $$\nThe problem requires the answer to be rounded to four significant figures. Therefore, the final result is $30.40 \\ \\mathrm{nmol \\ mg^{-1}}$.", "answer": "$$\n\\boxed{30.40}\n$$", "id": "4913173"}, {"introduction": "The clinical consequence of atherosclerosis often hinges on the structural integrity of the plaque's fibrous cap. This exercise models the cap's thickness as a dynamic equilibrium between collagen synthesis by smooth muscle cells and its degradation by matrix metalloproteinases (MMPs). Through this model [@problem_id:4913189], you will calculate how pro-inflammatory signals can shift this balance toward net degradation, leading to cap thinning and an increased risk of plaque rupture.", "problem": "A fibrous cap overlies an atherosclerotic plaque. Let the total collagen content of the cap be $C(t)$, measured as mass, and assume the cap covers a constant cross-sectional area $A$ with collagen mass density $\\rho$, so that cap thickness is $h(t)$ satisfying $C(t)=\\rho A h(t)$. In a quiescent, stable smooth muscle cell (SMC) phenotype, collagen synthesis by vascular smooth muscle cells (SMCs) can be approximated as a zero-order process with a constant rate $S_{\\mathrm{SMC}}$ (mass per unit time), while degradation by matrix metalloproteinases (MMPs) is well-approximated as a first-order process with respect to collagen content, with an effective rate constant $k_{d} M$, where $k_{d}$ is a proportionality constant and $M$ is a measure of active MMP abundance or activity.\n\nStarting from the principle of mass balance, derive a differential equation governing $C(t)$ and use it to obtain the steady-state cap thickness $h^{\\ast}$ in terms of $S_{\\mathrm{SMC}}$, $k_{d}$, $M$, $\\rho$, and $A$. Then, consider a pro-inflammatory shift in the plaque environment in which SMC collagen synthesis decreases by a factor of $0.70$ and MMP activity increases by a factor of $1.50$, with $k_{d}$, $\\rho$, and $A$ unchanged. Using your derived expression, compute the ratio $r$ of the new steady-state cap thickness to the baseline steady-state cap thickness, $r = h^{\\ast}_{\\mathrm{new}}/h^{\\ast}_{\\mathrm{old}}$. Express the final ratio as a reduced fraction. No units are required for the final ratio, and no rounding is necessary.", "solution": "We begin from the conservation (mass balance) principle for a constituent in a control volume. The net rate of change of the collagen mass $C(t)$ in the fibrous cap equals the sum of its sources minus sinks. Under the stated assumptions, synthesis by vascular smooth muscle cells (SMCs) proceeds at a constant zero-order rate $S_{\\mathrm{SMC}}$ (mass per unit time), while degradation mediated by matrix metalloproteinases (MMPs) follows first-order kinetics with respect to $C(t)$, with an effective degradation rate constant $k_{d} M$ (per unit time). Therefore, the mass balance is\n$$\n\\frac{dC}{dt} = S_{\\mathrm{SMC}} - (k_{d} M)\\, C(t).\n$$\nA steady state is defined by $\\frac{dC}{dt}=0$. Setting the left-hand side to zero and solving for $C^{\\ast}$ gives\n$\n0 = S_{\\mathrm{SMC}} - (k_{d} M)\\, C^{\\ast}\n$\nso\n$$\nC^{\\ast} = \\frac{S_{\\mathrm{SMC}}}{k_{d} M}.\n$$\nCap thickness $h(t)$ is related to collagen mass by $C(t) = \\rho A h(t)$. At steady state,\n$\nC^{\\ast} = \\rho A h^{\\ast}\n$,\nhence\n$$\nh^{\\ast} = \\frac{C^{\\ast}}{\\rho A} = \\frac{S_{\\mathrm{SMC}}}{\\rho A\\, k_{d} M}.\n$$\nWe now analyze how changes in synthesis and degradation affect the steady-state thickness. Let the baseline steady state be\n$\nh^{\\ast}_{\\mathrm{old}} = \\frac{S_{\\mathrm{SMC,old}}}{\\rho A\\, k_{d} M_{\\mathrm{old}}}.\n$\nAfter a pro-inflammatory shift, suppose SMC collagen synthesis decreases by a multiplicative factor of $0.70$ and MMP activity increases by a factor of $1.50$, with $k_{d}$, $\\rho$, and $A$ unchanged. Then\n$\nS_{\\mathrm{SMC,new}} = 0.70\\, S_{\\mathrm{SMC,old}}\n$\nand\n$\nM_{\\mathrm{new}} = 1.50\\, M_{\\mathrm{old}}.\n$\nThe new steady-state thickness is\n$\nh^{\\ast}_{\\mathrm{new}} = \\frac{S_{\\mathrm{SMC,new}}}{\\rho A\\, k_{d} M_{\\mathrm{new}}}.\n$\nThe ratio $r$ of new to old steady-state thickness is\n$$\nr \\equiv \\frac{h^{\\ast}_{\\mathrm{new}}}{h^{\\ast}_{\\mathrm{old}}} = \\frac{\\dfrac{S_{\\mathrm{SMC,new}}}{\\rho A\\, k_{d} M_{\\mathrm{new}}}}{\\dfrac{S_{\\mathrm{SMC,old}}}{\\rho A\\, k_{d} M_{\\mathrm{old}}}} = \\frac{S_{\\mathrm{SMC,new}}}{S_{\\mathrm{SMC,old}}}\\cdot \\frac{M_{\\mathrm{old}}}{M_{\\mathrm{new}}}.\n$$\nSubstituting the specified fold-changes,\n$$\nr = 0.70 \\cdot \\frac{1}{1.50} = \\frac{0.70}{1.50}.\n$$\nWriting the ratio as a reduced fraction, we note that $0.70 = \\frac{7}{10}$ and $1.50 = \\frac{3}{2}$. Therefore,\n$$\nr = \\frac{\\tfrac{7}{10}}{\\tfrac{3}{2}} = \\frac{7}{10} \\cdot \\frac{2}{3} = \\frac{14}{30} = \\frac{7}{15}.\n$$\nThus, the new steady-state cap thickness is reduced to a fraction $r = \\frac{7}{15}$ of the baseline steady-state cap thickness.", "answer": "$$\\boxed{\\frac{7}{15}}$$", "id": "4913189"}]}